Tyra Biosciences, Inc. Common Stock
Symbol: TYRA (NASDAQ)
0.00
▼ (-100.00%) -13.990
Company Description:
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $13.99
- Yesterday High: $14.02
- Yesterday Low: $13.26
- Yesterday Volume: 152.21K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Tyra Biosciences, Inc. Common Stock
- Website: https://www.tyra.bio
- Listed Date: 2021-09-15
- Location: CARLSBAD, CA
- Market Status: Active
- CIK Number: 0001863127
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $708.85M
- Round Lot: 100
- Outstanding Shares: 53.30M
- Asset Type: CS
RECENT FILINGS FOR TYRA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-17 | 4 | View |
| 2025-08-22 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 4 | View |
| 2025-08-07 | 4 | View |
| 2025-08-07 | 4 | View |
| 2025-08-07 | 4 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-18 | 144 | View |
| 2025-06-17 | 144 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 144 | View |
| 2025-06-13 | 144 | View |
| 2025-06-12 | 144 | View |
| 2025-06-11 | 4 | View |
| 2025-06-06 | SCHEDULE 13D/A | View |
Latest News on TYRA